Meet KinderPharm, our paediatric co-development partner.
Paediatric drug development is now an integral part of drug development both in the US and EU. Although there has been significant progress in establishing the regulatory framework for paediatric drug development in the US and EU, many clinical, scientific, technical and regulatory challenges still remain for paediatric product labelling.
KinderPharm and Auxiliis are the first dedicated and fully integrated paediatric drug-development companies. Our common mission is to be your expert paediatric co-development partners and the outsourced “Paediatric Center of Excellence” for your organization.
We have a single goal of “Bringing Better Medicines to Children”. We strive to apply the best available scientific, technical, clinical and quality practices to serve the needs of our patients and deliver value to our customers. We believe our integrated “one-stop” service model enables us to efficiently and cost-effectively advance paediatric products through all the required stages of pre-clinical and clinical development.
Our comprehensive portfolio of paediatric development capabilities, combined with the talents and experience of our people, provides us with a unique set of expertise, skill and insight to tackle the most challenging of development issues